Company intelligence / Profile preview

BSQUARED Capital

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

BSQUARED Capital is an active investor in private growth-stage life science and biotech companies. For example, it was a participant in the $100M Series C funding for SiteOne Therapeutics, which develops non-opioid pain drugs.

Industry: Investors

Partnerships

Investment partnerships, e.g. with Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital in syndicate deals

Beyond the preview

Go deeper on BSQUARED Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BSQUARED Capital.

Explore the full profile